When the half-maximal inhibitory concentration (IC50) was calculated, we observed that a higher dose of the drugs was needed for breast cancer cell lines expressing COMP to achieve effect similar to the mock cells (Fig. S2). This evidence concerns the gene COMP and breast carcinoma.